Ethical Compliance
SUN PHARMACEUTICAL IND L
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
2.1%
Debt
3.3%
Liquidity
12.3%
Revenue
Debt
Liquidity
2.1%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Other Income | ₹331.29 |
| government grant | ₹738.40 |
| Sale of products | ₹47,130.45 |
| Sale of service | ₹628.00 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹1,022.91 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹1,022.91 |
| Total: | ₹1,022.91 |
| Total Revenue: | ₹49,851.04 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹1,022.91
₹49,851.04
= 2.1%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
